Philippe L Salome
Philippe L Salome has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Corine Den Engelsen
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands
2 shared publications - Guy E. H. M. Rutten
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands
2 shared publications - Kees J. Gorter
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
2 shared publications - Annerika H. M. Slok
Department of Family Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands
1 shared publication - Daniel Kotz
Institut für Allgemeinmedizin (ifam), Schwerpunkt Suchtforschung und klinische Epidemiologie, Centre for Health and Society (chs), Medizinische Fakultät und Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Deutschland
1 shared publication - Denise Schuiten
PICASSO foundation for COPD, Alkmaar, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 7 August 2014
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 14 (1) , 131
Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care
Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients. Since there is no cure, the goal of treating COPD is to maintain or improve quality of life. We have developed a new tool, the Assessment of Burden of COPD (ABC) tool, to assess and visualize the integrated health status of patients with COPD, and to provide patients and healthcare providers with a treatment algorithm. This tool may be used during consultations to monitor the burden of COPD and to adjust treatment if necessary. The aim of the current study is to analyse the effectiveness of the ABC tool compared with usual care on health related quality of life among COPD patients over a period of 18 months.
- 7 August 2014
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 14 (1) , 131
Open AccessEffectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care
Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients. Since there is no cure, the goal of treating COPD is to maintain or improve quality of life. We have developed a new tool, the Assessment of Burden of COPD (ABC) tool, to assess and visualize the integrated health status of patients with COPD, and to provide patients and healthcare providers with a treatment algorithm. This tool may be used during consultations to monitor the burden of COPD and to adjust treatment if necessary. The aim of the current study is to analyse the effectiveness of the ABC tool compared with usual care on health related quality of life among COPD patients over a period of 18 months.
- Open Access
- 13 September 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 778
Remission of screen-detected metabolic syndrome and its determinants: an observational study
Early detection and treatment of the metabolic syndrome may prevent diabetes and cardiovascular disease. Our aim was to assess remission of the metabolic syndrome and its determinants after a population based screening without predefined intervention in the Netherlands.
- 13 September 2012
- Published by Springer Nature in BMC Public Health
- Vol. 12 (1) , 778
Open AccessRemission of screen-detected metabolic syndrome and its determinants: an observational study
Early detection and treatment of the metabolic syndrome may prevent diabetes and cardiovascular disease. Our aim was to assess remission of the metabolic syndrome and its determinants after a population based screening without predefined intervention in the Netherlands.
- Open Access
- 1 January 2012
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 11 (1) , 25
High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis
People with central obesity have an increased risk for developing the metabolic syndrome, type 2 diabetes and cardiovascular disease. However, a substantial part of obese individuals have no other cardiovascular risk factors, besides their obesity. High sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. We evaluated the use of hs-CRP to discriminate between centrally obese people with and without the metabolic syndrome.
- 1 January 2012
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 11 (1) , 25
Open AccessHigh-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis
People with central obesity have an increased risk for developing the metabolic syndrome, type 2 diabetes and cardiovascular disease. However, a substantial part of obese individuals have no other cardiovascular risk factors, besides their obesity. High sensitivity C-reactive protein (hs-CRP), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. We evaluated the use of hs-CRP to discriminate between centrally obese people with and without the metabolic syndrome.